Inventor
Christoph H. Ladel
Inventor
Darmstadt, DE
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes28%
C07KPeptides17%
A61FFilters implantable into blood vessels6%
A61LMethods or apparatus for sterilising materials or objects in general6%
C08LCompositions of macromolecular compounds6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
PatentTitleYear
10,221,456Genetic markers for predicting responsiveness to FPG-18 compound201910,086,112Implant comprising FGF-1820189,889,179'FGF-18 compound dosing regimen'20189,724,388'FGF-18 compound dosing regimen'20178,207,115'Treatment of cartilage disorders with FGF-18'20128,034,817'Treatment of bacterial diseases of the respiratory organs'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011Patents assigned to Bayer Pharma AG (1)· patent assignee history
2011Based in Ivrea, IT· patent location history
2012Patents assigned to ARES TRADING SA (1)· patent assignee history
2012Patents assigned to GIMONA ALBERTO (1)· patent assignee history
2012Patents assigned to LADEL CHRISTOPH H (1)· patent assignee history
2012Based in Nyon, CH· patent location history
2017–2019Patents assigned to MERCK PATENT GMBH (4)· patent assignee history
2017–2019Based in Darmstadt, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK PATENT GMBH | 4 | 2017–2019 |
| ARES TRADING SA | 1 | 2012 |
| Bayer Pharma AG | 1 | 2011 |
| GIMONA ALBERTO | 1 | 2012 |
| LADEL CHRISTOPH Hself | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Darmstadt, DE | 4 | 2017–2019 |
| Nyon, CH | 1 | 2012 |
| Ivrea, IT | 1 | 2011 |